Skip to content

    HIV & AIDS Health Center

    Font Size

    Drug Resistance Not Always to Blame When HIV Treatment Fails

    WebMD Health News

    Jan. 11, 2000 (Atlanta) -- HIV treatments fail for more reasons than previously recognized, according to two new studies in this week's edition of the Journal of the American Medical Association. However, new tests may be able to expand the number of treatment options remaining to patients whose first anti-HIV drug regimen no longer works.

    When combination HIV therapy fails, doctors usually assume one of two things: Either the virus has developed the ability to resist the drugs, or the patient has not taken the drugs as prescribed. The studies show that for patients in whom treatment stops working soon after it is begun, resistance to the most potent drugs in the combination is not usually the problem.

    "There are many reasons why drug regimens fail patients," Diane V. Havlir, MD, lead author of one of the studies, tells WebMD. "Resistance testing might help define the optimal therapy for a patient in that situation. Not all of the drugs in a treatment regimen might be resistant to HIV."

    "The cause of the failure in this trial seems to be related to problems with adherence ... and is related to the potency of the drugs," Françoise Brun-Vézinet, MD, PhD, lead investigator of the second study, tells WebMD.

    Both research teams point to their findings as evidence -- not proof -- that only the drugs to which HIV has developed resistance need to be replaced in a failing regimen. Brun-Vézinet and Havlir both warn that this is a risky proposition, but that it is worth testing in the face of limited treatment options.

    Brun-Vézinet insists that drugs that are hard for patients to take can be just as ineffective as drugs to which HIV has developed resistance. "We need very simple drugs to take," says the director of the virology laboratory at Bichat-Claude Bernard Hospital, Paris. "What we learned very early is that this is a chronic infection; patients will take the drugs all their lives. The pharmaceutical companies need to push efforts to make anti-HIV drugs very easy to take. We need to support patients and to help patients to take drugs in appropriate fashions. That means that we need to have some unique person in the clinical department who will be devoted to helping patients to take the drugs. It is a very important problem because it is a reason for treatment failure."

    Today on WebMD

    How much do you know?
    contemplative man
    What to do now.
    Should you be tested?
    HIV under microscope
    What does it mean?
    HIV AIDS Screening
    man opening condom wrapper
    HIV AIDS Treatment
    Discrimination Stigma
    Treatment Side Effects
    grilled chicken and vegetables
    obese man standing on scale
    cold sore